Heterogeneity of treatment effect of higher dose dexamethasone by geographic region (Europe vs. India) in patients with COVID-19 and severe hypoxemia – a post hoc evaluation of the COVID STEROID 2 trial

https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(23)00153-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lansea&utm_campaign=update-lansea&utm_medium=email&_hsmi=290843425&_hsenc=p2ANqtz-8uCv2xG044i4_0OKNBciLdM_IKd1dfxXj6aj9XfxZ16KJPqFRFi9iBXTJsmSQKMZa8PG8g7yA-O1i-0c6QljSanQ0Awg&utm_content=290650877&utm_source=hs_email